Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

ZBIO Stock Notice: Zenas BioPharma, Inc. Stockholders are Encouraged to Contact Shareholder Rights Law Firm Robbins LLP for Information About the ZBIO Class Action

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to the registration statement and related prospectus …

EODHD | 05 May 2025

President Trump says he will call CEOs personally as he gets more involved in corporate America: ‘Wouldn’t you want me to call?’

President Donald Trump said in a Meet the Press interview Sunday that he would not hesitate to call CEOs that he doesn’t agree with. Trump said he called Amazon executive chairman Jeff Bezos to complain about a report that said Amazon was set to …

EODHD | 05 May 2025

NSSC Stock News: Stockholders with Large Losses Should Contact Robbins LLP for Information on the Class Action Lawsuit Against Napco Security Technologies, Inc.

SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Napco Security Technologies, Inc. (NASDAQ: NSSC) securities between February 5, 2024 and February 3, 2025. Napco …

EODHD | 05 May 2025

OpenAI Reaches Agreement to Buy Startup Windsurf for $3 Billion

(Bloomberg) — OpenAI has agreed to buy Windsurf, an artificial intelligence-assisted coding tool formerly known as Codeium, for about $3 billion, according to people familiar with the matter, marking the ChatGPT maker’s largest acquisition to date. Most Read from Bloomberg The Battle Over the …

EODHD | 05 May 2025

ONE Gas (OGS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2025, ONE Gas (OGS) reported revenue of $935.19 million, up 23.3% over the same period last year. EPS came in at $1.98, compared to $1.75 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of …

EODHD | 05 May 2025

Kirby McInerney LLP Announces Investigation of Potential Claims Against Arvinas, Inc. (ARVN) on Behalf of Investors

NEW YORK , May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ:ARVN). The investigation concerns whether Arvinas and/or certain of its officers have violated the federal securities laws. …

EODHD | 05 May 2025

Kirby McInerney LLP Urges Investors in Actinium Pharmaceuticals, Inc. (ATNM) to Inquire About Their Rights in Class Action Lawsuit

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Actinium …

EODHD | 05 May 2025

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Civitas Resources, Inc. (CIVI)

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons or entities who purchased or …

EODHD | 05 May 2025

Big Oil Isn’t Backing Down at $60 Oil

Big Oil majors have no plans to scale back their budgets despite oil prices softening and more barrels poised to hit the market. That may sound reckless in a bearish environment, but it’s anything but. With demand picking up in Asia and OPEC+ preparing …

EODHD | 05 May 2025

Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025

SAN FRANCISCO and SUZHOU, China, May 6, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announces that the latest 1-year …

EODHD | 05 May 2025
Support

Hi! How can we help you today?

Loading…